Applications are open
Apply Today
Reinfections of seasonal coronaviruses are frequent, according to new research that suggests that the coronavirus behind the current pandemic could also produce reinfections.
Several states are loosening their coronavirus restrictions on restaurants and other businesses because of improved infection and hospitalization numbers but are moving cautiously, in part because of the more contagious variant taking hold.
The Covid-19 vaccines authorized in the U.S. are approximately 95% effective at preventing people from getting sick with symptoms, according to Pfizer and Moderna, the companies that produce them. But scientists are still studying whether vaccination prevents transmission to others.
This week, the University of Michigan School of Public Health hosted a virtual discussion with epidemiologists Arnold Monto and Emily Martin on what we currently know about the COVID-19 vaccines. Here are five key takeaways from the event.
The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers, a step that will likely help clear the way for emergency authorization by the Food and Drug Administration.
Here are three key takeaways from the December 2 discussion on vaccine development with infectious disease expert and University of Michigan School of Public Health professor Arnold Monto.